MC-1-50

BIOLOGICAL3 trials

Sponsors

Chongqing Precision Biotech Co., Ltd

Conditions

Acute Lymphoblastic Leukemia, in RelapseB Cell LymphomaNon Hodgkin LymphomaRefractoryRefractory Acute Lymphoblastic LeukemiaSystemic Lupus Erythematosus (SLE)

Phase 1

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

RecruitingNCT06180174

Chongqing Precision Biotech Co., LtdB Cell Lymphoma, Non Hodgkin Lymphoma

Start: 2023-12-31End: 2026-12-31Target: 24Updated: 2023-12-28

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

Not yet recruitingNCT06641024

Chongqing Precision Biotech Co., LtdAcute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia

Start: 2024-11-01End: 2039-11-01Target: 24Updated: 2024-10-15

Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE

RecruitingNCT06892145

Chongqing Precision Biotech Co., LtdRefractory, Systemic Lupus Erythematosus (SLE)

Start: 2025-06-12End: 2028-02-16Target: 12Updated: 2025-12-22